{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:17:25Z","timestamp":1675361845489},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.transproceed.2015.05.025","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T03:27:01Z","timestamp":1439954821000},"page":"1741-1745","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early or Late Conversion From Tac-BD to Tac-BD in Renal Transplantation: When is the Right Time?"],"prefix":"10.1016","volume":"47","author":[{"given":"S.J.","family":"Falconer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.R.","family":"Peagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Oniscu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2015.05.025_bib1","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/j.1600-6143.2007.01966.x","article-title":"A\u00a0retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients","volume":"7","author":"Takemoto","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.05.025_bib2","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2165\/00003495-200767130-00012","article-title":"Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients","volume":"67","author":"Cross","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2015.05.025_bib3","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study","volume":"10","author":"Kramer","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.05.025_bib4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/j.1600-6143.2010.03255.x","article-title":"Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation","volume":"10","author":"Trunecka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.05.025_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.transproceed.2010.03.106","article-title":"Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients","volume":"42","author":"Comuzzi","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.05.025_bib6","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.transproceed.2009.05.014","article-title":"De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels","volume":"41","author":"Crespo","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.05.025_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/TP.0b013e3182292426","article-title":"Lower Variability of tacrolimus trough concentration after conversion from Prograf to Advagraf in stable kidney transplant recipients","volume":"92","author":"Wu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.05.025_bib8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.transproceed.2011.02.049","article-title":"Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen","volume":"43","author":"Mecule","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.05.025_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3182a203bd","article-title":"OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation","volume":"96","author":"Albano","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.05.025_bib10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.transproceed.2011.01.089","article-title":"Advagraf de novo in liver transplantation: a single-center experience","volume":"43","author":"Ortiz de Urbina","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.05.025_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.transproceed.2004.12.222","article-title":"Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen","volume":"37","author":"Alloway","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.05.025_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/TP.0b013e3182098ff0","article-title":"Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure","volume":"91","author":"Hougardy","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.05.025_bib13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2165\/11593890-000000000-00000","article-title":"Once- versus twice-daily tacrolimus: are the formulations truly equivalent?","volume":"71","author":"Barraclough","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2015.05.025_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/TP.0b013e31823aa56e","article-title":"The once-daily formulation of tacrolimus: a step forward in kidney transplantation?","volume":"93","author":"Hougardy","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.05.025_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.transproceed.2011.11.005","article-title":"Conversion of stable kidney transplant recipients from a twice-daily Prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism","volume":"44","author":"Uchida","year":"2012","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515005394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515005394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:58:37Z","timestamp":1537405117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134515005394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0041134515005394"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.05.025","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early or Late Conversion From Tac-BD to Tac-BD in Renal Transplantation: When is the Right Time?","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}